FUSN - Fusion Pharmaceuticals GAAP EPS of -$0.40
2024-05-07 07:41:07 ET
More on Fusion Pharmaceuticals
- What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals
- Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook
- Fusion Pharmaceuticals GAAP EPS of -$0.39 misses by $0.06
- AstraZeneca-Fusion deal reignites radiopharma space
- Seeking Alpha’s Quant Rating on Fusion Pharmaceuticals